Nocturnal home hemodialysis associates with improvement of electrocardiographic features linked to sudden cardiac death

ASAIO Journal

Volumn 60, Issue 1, 2014, Pages 99-105

  Thomson, Benjamin K A ^a,b   Huang, Shi Han S ^a,b   Chan, Christopher ^c   Urquhart, Bradley ^a,b   Skanes, Allan ^a   Lindsay, Robert M ^a,b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Hemodialysis; home hemodialysis; nocturnal hemodialysis; QRS amplitude variation; quotidian dialysis; sudden cardiac death; Tpeak to Tend

Indexed keywords

AMPLITUDE VARIATIONS; HEMODIALYSIS; HOME HEMODIALYSIS; NOCTURNAL HEMODIALYSIS; SUDDEN CARDIAC DEATHS; TPEAK TO TEND;

ELECTROCARDIOGRAPHY; HEMODIALYZERS;

DIALYSIS;

ADULT; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HOME DIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; QRS COMPLEX; REVIEW; SUDDEN CARDIAC DEATH; T WAVE AMPLITUDE; YOUNG ADULT;

ADULT; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEMODIALYSIS, HOME; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84891851858     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000023     Document Type: Review

References (51)

1. Rich A: Morbidity and mortality. In: USRDS 2008 Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008, pp. 129-146.
2. Genovesi S, Valsecchi MG, Rossi E, et al: Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant 24: 2529-2536, 2009.
3. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G: Characteristics of sudden death in hemodialysis patients. Kidney Int 69: 2268-2273, 2006.
4. Paoletti E, Specchia C, Di Maio G, et al: The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10 year survey. Nephrol Dial Transplant 19: 1829-1834, 2004.
5. Genovesi S, Rivera R, Fabbrini P, et al: Dynamic QT interval analysis in uraemic patients receiving chronic haemodialysis. J Hypertens 21: 1921-1926, 2003.
6. Genovesi S, Dossi C, Viganò MR, et al: Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace 10: 771-777, 2008.
7. Severi S, Grandi E, Pes C, Badiali F, Grandi F, Santoro A: Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: In vivo and in silico analysis. Nephrol Dial Transplant 23: 1378-1386, 2008.
8. Näppi SE, Virtanen VK, Saha HH, Mustonen JT, Pasternack AI: QTc dispersion increases during hemodialysis with low-calcium dialysate. Kidney Int 57: 2117-2122, 2000.
9. Jefferies HJ, Virk B, Schiller B, Moran J, McIntyre CW: Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 6: 1326-1332, 2011.
10. Jefferies HJ, Burton JO, McIntyre CW: Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability. Blood Purif 32: 63-68, 2011.
11. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysisinduced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4: 914-920, 2009.
12. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Cholesterol and recurrent events trial investigators: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633, 2003.
13. Korsheed S, Burton JO, McIntyre CW: Higher arteriovenous fstulae blood fows are associated with a lower level of dialysis-induced cardiac injury. Hemodial Int 13: 505-511, 2009.
14. Silberberg J, Racine N, Barre P, Sniderman AD: Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 6: 1-4, 1990.
15. London GM, Marchais SJ, Guerin AP, Métivier F: Contributive factors to cardiovascular hypertrophy in renal failure. Am J Hypertens 2(11 pt 2): 261S-263S, 1989.
16. Macdougall IC, Lewis NP, Saunders MJ, et al: Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoi-etin. Lancet 335: 489-493, 1990.
17. London GM, Zins B, Pannier B, et al: Vascular changes in hemodialysis patients in response to recombinant human erythropoi-etin. Kidney Int 36: 878-882, 1989.
18. Parfrey PS, Foley RN, Harnett JD, et al: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11: 1277-1285, 1996.
19. Amann K, Breitbach M, Ritz E, Mall G: Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 9: 1018-1022, 1998.
20. Amann K, Kronenberg G, Gehlen F, et al: Cardiac remodeling in experimental renal failure-An immunohistochemical and molecular study. Nephrol Dial Transplant 13: 1958-1966, 1998.
21. Haigney MC, Zareba W, Gentlesk PJ, et al; Multicenter Automatic Defbrillator Implantation Trial II investigators: QT interval variability and spontaneous ventricular tachycardia or fbrillation in the Multicenter Automatic Defbrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 44: 1481-1487, 2004.
22. Shapira OM, Bar-Khayim Y: ECG changes and cardiac arrhythmias in chronic renal failure patients on hemodialysis. J Electrocardiol 25: 273-279, 1992.
23. Suzuki R, Tsumura K, Inoue T, Kishimoto H, Morii H: QT interval prolongation in the patients receiving maintenance hemodialy-sis. Clin Nephrol 49: 240-244, 1998.
24. Nearing BD, Verrier RL: Progressive increases in complexity of T-wave oscillations herald ischemia-induced ventricular fbril-lation. Circ Res 91: 727-732, 2002.
25. Gehi AK, Stein RH, Metz LD, Gomes JA: Microvolt T-wave alternans for the risk stratifcation of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46: 75-82, 2005.
26. Chow T, Kereiakes DJ, Bartone C, et al: Prognostic utility of microvolt T-wave alternans in risk stratifcation of patients with isch-emic cardiomyopathy. J Am Coll Cardiol 47: 1820-1827, 2006.
27. Chinushi M, Hosaka Y, Washizuka T, Furushima H, Aizawa Y: Arrhythmogenesis of T wave alternans associated with surface QRS complex alternans and the role of ventricular prematurity: Observations from a canine model of LQT3 syndrome. J Cardiovasc Electrophysiol 13: 599-604, 2002.
28. Maury P, Metzger J: Alternans in QRS amplitude during ventricular tachycardia. Pacing Clin Electrophysiol 25: 142-150, 2002.
29. Hoher M, Wohrle J, Scharf B, et al: Heart-rate dependency of QRS-microvariablility during atrial pacing. Compute Cardiol 727-730, 2000.
30. Yamazaki T, Froelicher VF, Myers J, Chun S, Wang P: Spatial QRS-T angle predicts cardiac death in a clinical population. Heart Rhythm 2: 73-78, 2005.
31. Zhu-Ming Z, Prineas RJ, Case D, Soliman EZ, Rautaharju PM, ARIC Research Group: Comparison of the prognostic signif-cance of the electrocardiographic QRS/T angles in predicting incident coronary heart disease and total mortality (from the Atherosclerosis Risk in Communities Study). Am J Cardiol 100: 844-849, 2007.
32. Teodorescu C, Reinier K, Uy-Evanado A, et al: Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization. Heart Rhythm 8: 1562-1567, 2011.
33. Shimizu M, Ino H, Okeie K, et al: T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardio-myopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 25: 335-339, 2002.
34. Watanabe N, Kobayashi Y, Tanno K, et al: Transmural dispersion of repolarization and ventricular tachyarrhythmias. J Electrocardiol 37: 191-200, 2004.
35. Yamaguchi M, Shimizu M, Ino H, et al: T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: A new index for arrhythmogenicity. Clin Sci (Lond) 105: 671-676, 2003.
36. Topilski I, Rogowski O, Rosso R, et al: The morphology of the QT interval predicts torsade de pointes during acquired bradyar-rhythmias. J Am Coll Cardiol 49: 320-328, 2007.
37. Rocco MV, Lockridge RS Jr, Beck GJ, et al; Frequent Hemodialysis Network (FHN) Trial Group: The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 80: 1080-1091, 2011.
38. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfeld P: Improved sex-specifc criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: Validation with autopsy fndings. Circulation 75: 565-572, 1987.
39. Sokolow M, Lyon TP: The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 37: 161-186, 1949.
40. Okin PM, Roman MJ, Devereux RB, Pickering TG, Borer JS, Kligfeld P: Time-voltage QRS area of the 12-lead electrocardiogram: Detection of left ventricular hypertrophy. Hypertension 31: 937-942, 1998.
41. Karnik JA, Young BS, Lew NL, et al: Cardiac arrest and sudden death in dialysis units. Kidney Int 60: 350-357, 2001.
42. Bleyer AJ, Russell GB, Satko SG: Sudden and cardiac death rates in hemodialysis patients. Kidney Int 55: 1553-1559, 1999.
43. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12: 2131-2138, 2001.
44. Kovesdy CP, Regidor DL, Mehrotra R, et al: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2: 999-1007, 2007.
45. Al-Hejaili F, Kortas C, Leitch R, et al: Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 14: 2322-2328, 2003.
46. Culleton BF, Walsh M, Klarenbach SW, et al: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 298: 1291-1299, 2007.
47. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61: 2235-2239, 2002.
48. Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S: Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and infammatory markers: A prospective, controlled study. J Am Soc Nephrol 16: 2778-2788, 2005.
49. Saragoca MA, Canziani ME, Cassiolato JL, et al: Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients. J Cardiovasc Pharmacol 17(supp 2): S136-S138, 1991.
50. London GM, Pannier B, Guerin AP, et al: Alterations of left ventricular hypertrophy in and survival of patients receiving hemo-dialysis: Follow-up of an interventional study. J Am Soc Nephrol 12: 2759-2767, 2001.
51. Kalantzi K, Korantzopoulos P, Bechlioulis A, et al: The Infuence of Hemodialysis on Novel Electrocardiographic Indexes of Arrhythmic risk in patients with end stage renal disease. Abstract from the 48th ERA-EDTA Congress, June 23-26, 2011, Prague, Czech Republic, IN: NDT Plus 4 (supplement 2), 2011.